David Kim has represented both issuers and investment banks on a variety of capital markets and corporate transactions, including initial public offerings and other equity offerings, high-yield, investment-grade and convertible debt offerings. David also counsels public companies with respect to general corporate and securities matters, including SEC reporting obligations and corporate governance.

Download full bio 


  • PROCEPT BioRobotics – $188.5 Million IPO 

  • Erasca – $345 Million IPO 

  • Ventyx Biosciences – $174.3 Million IPO 


  • Georgetown University Law Center
    JD, 2017

  • New York University
    BS, Media, Culture & Communication
    magna cum laude, 2014

Admissions & Credentials

New York

Not admitted to practice in California